Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
1.020
-0.040 (-3.77%)
Nov 7, 2025, 4:00 PM EST - Market closed
Scinai Immunotherapeutics Employees
Scinai Immunotherapeutics had 31 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
31
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$37,000
Profits / Employee
$11,194
Market Cap
3.25M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31 | 0 | - |
| Dec 31, 2023 | 31 | -2 | -6.06% |
| Dec 31, 2022 | 33 | 18 | 120.00% |
| Dec 31, 2021 | 15 | -6 | -28.57% |
| Dec 31, 2020 | 21 | -4 | -16.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SCNI News
- 4 weeks ago - Scinai Awarded Israel Innovation Authority Grant to Expand Fill-and-Finish CDMO Capabilities - PRNewsWire
- 2 months ago - Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet - PRNewsWire
- 3 months ago - Scinai Announces New Peer-Reviewed Publication Supporting PC111 as a Disease-Modifying Therapy for Pemphigus and SJS/TEN - PRNewsWire
- 5 months ago - Scinai Highlights New Funding and CDMO Growth Ahead of BIO International Convention 2025 - PRNewsWire
- 5 months ago - Scinai Immunotherapeutics Receives Italian Government Clearance Under Golden Power Regulation for Potential Acquisition of Pincell S.r.l. - PRNewsWire
- 5 months ago - Scinai Reports Q1 2025 Financial Results Highlighting Strong CDMO Revenue Momentum and Reduced Cash Burn - PRNewsWire
- 6 months ago - Scinai Announces Annual Financial Results for 2024 - PRNewsWire
- 6 months ago - Scinai Immunotherapeutics and Pincell to Host Webinar on a Blockbuster Drug Candidate for Devastating Rare Skin Diseases - PRNewsWire